Fulgent Genetics, Inc. provided earnings guidance for the year 2024. For the year, The company expects total core revenues to be approximately $280 million for 2024, representing a core growth of 7% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.1 USD | +0.35% | -1.28% | -30.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.47% | 601M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-15.34% | 1.03B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024